Details
Category: Volume 08 Issue 04 April 2020
Hits: 2215

Title: Association of Diabetic Maculopathy with Common Systemic Comorbidities

Authors: Nethaji Sellaram S, Dalia S

 DOI: https://dx.doi.org/10.18535/jmscr/v8i4.36

Abstract

   

Purpose: To identify association of diabetic maculopathy with factors like hypertension, coronary artery disease (CAD), fasting lipid profile, serum urea and creatinine, HbA1c.

Design: Cross sectional study.

Materials and Methods: 150 patients were enrolled, their diabetic retinopathy and maculoapthy status were assessed. Optical coherence tomography (OCT) scan of macula was done. Patients systemic factors were assessed using clinical and laboratory tests.

Results: Out of 150 patients 50% had moderate NPDR, 22.7% with severe NPDR, 22.7% with PDR, 4.7% with mild NPDR changes. 84% of patients were having severe diabetic maculopathy. Duration of diabetes and hypertension, CAD showed no significant difference with the maculopathy severity. HDL cholesterol level showed signification association with diabetic maculoathy. HDL, LDL, urea, creatinine, HbA1c levels showed significant association with increase in central foveal thickness.

Conclusion: Poor glycemic control, hyperlipidemia and deranged renal function found to increase the diabetic macular edema.

Keywords: Diabetic Maculopathy; association; risk factors; OCT.

References

  1. Miljanovic B, Glynn RJ, Nathan DM, et al: A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes.  Diabetes2004; 53:2883-2892
  2. Zander E, Herfurth S, Bohl B, et al: Maculopathy in patients with diabetes mellitus type 1 and type 2: associations with risk factors. J. Ophthalmol 2000; 84:871-876.
  3. Teiko Yamamoto, Satoshi Iimuro et.al Prevalence and risk factors for diabetic maculopathy, and its relationship to diabetic retinopathy in elderly Japanese patients with type 2 diabetes mellitus. Geriatr GerontolInt 2012; 12 (Suppl. 1): 134–140g
  4. Klein R, Klein BEK, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy IV. Diabetic macular edema. Ophthalmology 1984;91:1464–74g
  5. Cugati S, Kifley A, Mitchell P, Wang JJ: Temporal trends in the age-specific prevalence of diabetes and diabetic retinopathy in older persons: Population-based survey findings.  Diabetes Res. Clin. Pract.2006
  6. Teiko Yamamoto, Satoshi Iimuro et.al Prevalence and risk factors for diabetic maculopathy, and its relationship to diabetic retinopathy in elderly Japanese patients with type 2 diabetes mellitus. Geriatr Gerontol Int 2012; 12 (Suppl. 1): 134–140g
  7. Ferris FL 3rd, Chew EY, Hoogwerf BJ. Serum lipids and diabetic retinopathy. Early treatment diabetic retinopathy study research group. Diabetes Care. 1996; 19:1291–3.
  8. Ding J, Wong TY. Current epidemiology of diabetic retinopathy and diabetic macular edema. CurrDiab Rep. 2012;12:346–54
  9. Aiello LM, Rand LI, Briones JC, et al. Nonocular clinical risk factors in the progression of diabetic retinopathy. In: Little HL, Jack RL, Patz A, Forsham PH, eds. Diabetic retinopathy. New York: Thieme-Stratton, 1983:21–31._
  10. Romero P, Baget M, Mendez I, et al. Diabetic macular edema and its relationship to renal microangiopathy: a sample of type I diabetes mellitus patients in a 15year follow up study. J Diabetes Complications. 2007;21:172–180.
  11. T-H Chou, P-C Wu et. al Relationship of diabetic macular oedema with glycosylated haemoglobin. Eye (2009) 23, 1360–1363
  12. Diabetes Control and Complications trial Research Group. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophthalmol 1995; 113: 36–51
  13. Klein R, Moss SE, Klein BE, Davis MD, De Mets DL. The Wisconsin epidemiological study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology 1989; 96: 1501–1510
  14. Klein R, Klein BEK, Moss SE, et al. Th e Wisconsin Epidemiologic Study of Diabetic Retinopthy XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 2008; 112:1217–28.
  15. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol1984; 102: 520–526.
  16. Stratton IM, Kohner EM, Aldington SJ et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia2001; 44: 156
  17. Cahill M, Halley A, Codd M et al. Prevalence of diabetic retinopathy in patients with diabetes mellitus diagnosed after the age of 70 years. Br J Ophthalmol 1997; 81: 218–222
  18. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Arch Intern Med 1989; 149: 2427– 2432

Corresponding Author

Nethaji Sellaram S

Department of Ophthalmology, Govt. TD Medical College, Alappuzha, Kerala – 688005, India